Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EASTMAN CHEMICAL COEMN · Entity 1780 | SVP & Chf. Mfg. Ofc. | February 24, 2026 | February 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EASTMAN CHEMICAL CO
Report date February 24, 2026 · Filed February 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Employee Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $77.12 · Expires 2036-02-23 | Direct | 33,223 |
Reported balance
After 2026-02-24 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-02-24 · Grant · Acquired 33,223 · Balance 33,223 F1: One-third of the options become exercisable on February 24, 2027, February 24, 2028, and February 24, 2029, respectively. |
| Restricted Stock UnitsSEC Table II · derivative / convertible security | Direct | 4,571 |
Reported balance
After 2026-02-24 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2026-02-24 · Grant · Acquired 4,571 · Balance 4,571 F2: Each restricted stock unit represents a contingent right to receive one share of issuer common stock. F3: The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 24, 2029, subject to continued employment. |
Filing footnotes · ownership attribution and instrument terms
F1: One-third of the options become exercisable on February 24, 2027, February 24, 2028, and February 24, 2029, respectively.
F2: Each restricted stock unit represents a contingent right to receive one share of issuer common stock.
F3: The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 24, 2029, subject to continued employment.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 24, 2026 Filed Feb 26, 2026 21:03 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantRestricted Stock Units · Derivative | 4,571 | $0.00 | $0.00 |
DisclosureSEC source: 0000915389-26-000062 · wk-form4_1772139782.xml · derivative · entry 2 Caveness Michelle H · CIK 0002051677 · SVP & Chf. Mfg. Ofc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,571 Underlying: Common Stock · 4,571 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of issuer common stock. F3 · derivative.exercise_date: The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 24, 2029, subject to continued employment. F3 · derivative.expiration_date: The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 24, 2029, subject to continued employment. Read SEC document |
| February 24, 2026 Filed Feb 26, 2026 21:03 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantEmployee Stock Option (right to buy) · Derivative | 33,223 | $0.00 Strike: $77.12 | $0.00 |
DisclosureSEC source: 0000915389-26-000062 · wk-form4_1772139782.xml · derivative · entry 1 Caveness Michelle H · CIK 0002051677 · SVP & Chf. Mfg. Ofc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,223 Underlying: Common Stock · 33,223 shares Expires 2036-02-23 F1 · derivative.exercise_date: One-third of the options become exercisable on February 24, 2027, February 24, 2028, and February 24, 2029, respectively. Read SEC document |
| February 18, 2026 Filed Feb 20, 2026 21:03 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Tax withholdingCommon Stock | 528 | $80.26 | $42,377.28 |
DisclosureSEC source: 0000915389-26-000045 · wk-form4_1771621407.xml · nonDerivative · entry 1 Caveness Michelle H · CIK 0002051677 · SVP & Chf. Mfg. Ofc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,655 F1 · shares: Shares of common stock withheld in payment of tax obligations related to the payout of performance shares for the 2023-2025 performance period. Read SEC document |
| February 11, 2026 Filed Feb 13, 2026 21:02 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantCommon Stock | 1,937 | $0.00 | $0.00 |
DisclosureSEC source: 0000915389-26-000025 · wk-form4_1771016536.xml · nonDerivative · entry 1 Caveness Michelle H · CIK 0002051677 · SVP & Chf. Mfg. Ofc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,183 F1 · shares: Determination of the number of performance shares earned for the three-year (2023- 2025) performance period. Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 20:01 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Exercise / conversionRestricted Stock Units · Derivative | 6,715 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000915389-25-000158 · wk-form4_1759435268.xml · derivative · entry 3 Caveness Michelle H · CIK 0002051677 · SVP & Chf. Mfg. Ofc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,715 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Payout of shares underlying restricted stock units on October 1, 2025, upon satisfaction of the applicable three-year vesting period. F1 · price: Payout of shares underlying restricted stock units on October 1, 2025, upon satisfaction of the applicable three-year vesting period. F1 · derivative.exercise_date: Payout of shares underlying restricted stock units on October 1, 2025, upon satisfaction of the applicable three-year vesting period. F1 · derivative.expiration_date: Payout of shares underlying restricted stock units on October 1, 2025, upon satisfaction of the applicable three-year vesting period. Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 20:01 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Tax withholdingCommon Stock | 1,636 | $61.96 | $101,366.56 |
DisclosureSEC source: 0000915389-25-000158 · wk-form4_1759435268.xml · nonDerivative · entry 2 Caveness Michelle H · CIK 0002051677 · SVP & Chf. Mfg. Ofc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,246 F2 · shares: Shares of common stock withheld in satisfaction of tax liability upon vesting of the 6,715 restricted stock units. Read SEC document |
| October 01, 2025 Filed Oct 2, 2025 20:01 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Exercise / conversionCommon Stock | 6,715 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000915389-25-000158 · wk-form4_1759435268.xml · nonDerivative · entry 1 Caveness Michelle H · CIK 0002051677 · SVP & Chf. Mfg. Ofc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Payout of shares underlying restricted stock units on October 1, 2025, upon satisfaction of the applicable three-year vesting period. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:06 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 1,147 | $0.00 Strike: $83.84 | $0.00 |
DisclosureSEC source: 0000915389-25-000057 · wk-form4_1741208775.xml · derivative · entry 3 Caveness Michelle H · CIK 0002051677 · SVP & Chf. Mfg. Ofc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,148 Underlying: Common Stock · 1,147 shares Expires 2033-02-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: One-third of option became exercisable on February 24, 2024, one-third of option became exercisable on February 24, 2025, and one-third of option becomes exercisable on February 24, 2026. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:06 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | SaleCommon Stock | 1,147 | $98.51 | $112,990.97 |
DisclosureSEC source: 0000915389-25-000057 · wk-form4_1741208775.xml · nonDerivative · entry 2 Caveness Michelle H · CIK 0002051677 · SVP & Chf. Mfg. Ofc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,167 Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 21:06 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Exercise / conversionCommon Stock | 1,147 | $83.84 | $96,164.48 |
DisclosureSEC source: 0000915389-25-000057 · wk-form4_1741208775.xml · nonDerivative · entry 1 Caveness Michelle H · CIK 0002051677 · SVP & Chf. Mfg. Ofc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,314 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:20 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantRestricted Stock Units · Derivative | 2,651 | $0.00 | $0.00 |
DisclosureSEC source: 0000915389-25-000051 · wk-form4_1740432026.xml · derivative · entry 2 Caveness Michelle H · CIK 0002051677 · SVP & Chf. Mfg. Ofc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,651 Underlying: Common Stock · 2,651 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one share of issue common stock. F3 · derivative.exercise_date: The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 20, 2028, subject to continued employment. F3 · derivative.expiration_date: The restricted stock units will vest and payout in unrestricted shares of Company common stock on the third anniversary of the grant date, February 20, 2028, subject to continued employment. Read SEC document |
| February 20, 2025 Filed Feb 24, 2025 21:20 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantEmployee Stock Option (right to buy) · Derivative | 13,881 | $0.00 Strike: $100.56 | $0.00 |
DisclosureSEC source: 0000915389-25-000051 · wk-form4_1740432026.xml · derivative · entry 1 Caveness Michelle H · CIK 0002051677 · SVP & Chf. Mfg. Ofc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,881 Underlying: Common Stock · 13,881 shares Expires 2035-02-19 F1 · derivative.exercise_date: One-third of the option becomes exercisable on February 20, 2026, February 20, 2027, and February 20, 2028, respectively. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:05 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | Tax withholdingCommon Stock | 440 | $103.47 | $45,526.80 |
DisclosureSEC source: 0000915389-25-000028 · wk-form4_1740085523.xml · nonDerivative · entry 2 Caveness Michelle H · CIK 0002051677 · SVP & Chf. Mfg. Ofc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,167 F2 · shares: Shares of common stock withheld in payment of tax liability incident to payout of performance shares. Read SEC document |
| February 18, 2025 Filed Feb 20, 2025 21:05 UTC | EASTMAN CHEMICAL CO EMN · Entity 1780 | GrantCommon Stock | 1,607 | $0.00 | $0.00 |
DisclosureSEC source: 0000915389-25-000028 · wk-form4_1740085523.xml · nonDerivative · entry 1 Caveness Michelle H · CIK 0002051677 · SVP & Chf. Mfg. Ofc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,607 F1 · shares: Payout of performance shares awarded at beginning of three-year (2022-2024) performance period. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.